The Dutch pharmaceutical company Merus is taken over by his Danish industry colleague Genmab. The Danes pay around $ 8 billion for the company from Utrecht that develops treatment for cancer in the head and neck area. The expectations around the drug are high and connoisseurs take into account a real blockbuster.
ttn-43
